current progress in the permeability and its enhancement approches for tcm active ingredients across blood-eye barrier
Clicks: 233
ID: 137215
2014
Article Quality & Performance Metrics
Overall Quality
Not rated
Combines reader engagement with the AI quality analysis. This
article has not been analysed, so there is no overall score —
reader engagement is measured and shown alongside.
Reader Engagement
Popular Article
30.0
/100
233 views
29 readers
AI Quality Assessment
Not analyzed
Readership in this journal
PopularRanked #86 of 133 articles by views in journal of fungi
Most read
Least read
Bar heights use a square-root scale. Only the 120 most-read articles are drawn; the journal has 133 in total.
Mint this article as an NFT
Not yet mintedCreate a permanent, verifiable on-chain record of this article on the Scimatic Network. The NFT is held in your Journament account, and you can withdraw it to your own wallet at any time.
5
SUSD
one-off · no wallet required
Abstract
Blood-eye barrier(BEB)is one of the most important structures of organism to maintain homeostasis of the eye. However, it is the major constraint for the medication of intraocular diseases. Traditional Chinese medicines have distinctive advantages for the treatment of intraocular diseases, which can be used to regulate the physiological function of human body with low toxicity. In this article, we have briefly summarized the feature of BEB, with the domestic and foreign literatures combined, and mainly reviewed current progress in the field of study on the permeability of traditional Chinese medicines and effective components in BEB and promoting methods.
| Reference Key |
bai2014guojicurrent
Use this key to autocite in the manuscript while using
SciMatic Manuscript Manager or Thesis Manager
|
|---|---|
| Authors | ;Yu-Yang Bai;You-Zhi Tang;Zhen Wang;Li-Na Liang;Shang-Kun Zhou;Yong-Sheng Yang |
| Journal | journal of fungi |
| Year | 2014 |
| DOI |
10.3980/j.issn.1672-5123.2014.10.16
|
| URL | |
| Keywords |
Citations
No citations found. To add a citation, contact the admin at info@scimatic.org
Comments
No comments yet. Be the first to comment on this article.